CRIS Current Research Information System

FARINA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.270
AS - Asia 10.077
EU - Europa 7.499
SA - Sud America 722
AF - Africa 510
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 25
Totale 31.129
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.083
SG - Singapore 2.925
CN - Cina 2.647
VN - Vietnam 2.170
GB - Regno Unito 1.835
IT - Italia 1.375
DE - Germania 948
SE - Svezia 813
HK - Hong Kong 680
BR - Brasile 542
UA - Ucraina 540
FR - Francia 492
IN - India 458
RU - Federazione Russa 402
IE - Irlanda 334
BD - Bangladesh 239
KR - Corea 209
JP - Giappone 196
ZA - Sudafrica 168
NL - Olanda 133
EE - Estonia 124
FI - Finlandia 111
TG - Togo 104
CH - Svizzera 97
CI - Costa d'Avorio 95
CA - Canada 82
ID - Indonesia 77
TH - Thailandia 75
AR - Argentina 73
PH - Filippine 71
MX - Messico 57
SC - Seychelles 56
BG - Bulgaria 54
TR - Turchia 47
IQ - Iraq 43
BE - Belgio 39
MY - Malesia 37
GR - Grecia 35
EC - Ecuador 34
AT - Austria 29
PL - Polonia 29
JO - Giordania 28
NG - Nigeria 24
SA - Arabia Saudita 24
CO - Colombia 21
EU - Europa 21
IR - Iran 21
ES - Italia 20
PK - Pakistan 20
AU - Australia 18
RO - Romania 16
VE - Venezuela 15
TW - Taiwan 14
UZ - Uzbekistan 14
LT - Lituania 13
MA - Marocco 13
LB - Libano 12
PY - Paraguay 12
AE - Emirati Arabi Uniti 10
CL - Cile 10
CR - Costa Rica 10
KE - Kenya 10
CZ - Repubblica Ceca 9
DK - Danimarca 9
NO - Norvegia 8
PE - Perù 8
EG - Egitto 7
IL - Israele 7
JM - Giamaica 7
PS - Palestinian Territory 7
HU - Ungheria 6
LK - Sri Lanka 6
MD - Moldavia 6
NP - Nepal 6
PT - Portogallo 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
MU - Mauritius 5
NZ - Nuova Zelanda 5
TN - Tunisia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CV - Capo Verde 4
CY - Cipro 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
HN - Honduras 4
OM - Oman 4
PR - Porto Rico 4
RS - Serbia 4
SV - El Salvador 4
UY - Uruguay 4
AM - Armenia 3
BO - Bolivia 3
DZ - Algeria 3
KH - Cambogia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
ZM - Zambia 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
Totale 31.091
Salva come PNG Salva come JPEG
Città #
Singapore 2.044
Southend 1.517
Fairfield 1.344
Ashburn 1.161
Chandler 682
Hong Kong 650
Woodbridge 645
Seattle 572
Wilmington 571
Ho Chi Minh City 556
Houston 536
Hefei 511
San Jose 508
Hanoi 432
Cambridge 415
Princeton 395
Jacksonville 385
Ann Arbor 358
Beijing 341
Santa Clara 331
Dublin 265
Boardman 252
Dong Ket 242
Bologna 238
Seoul 189
Lauterbourg 187
Los Angeles 178
Tokyo 178
Nanjing 171
Westminster 161
Padova 153
New York 150
Council Bluffs 149
Menlo Park 144
Berlin 123
Turin 110
Milan 108
Dallas 107
Buffalo 105
Lomé 104
Helsinki 100
Abidjan 93
San Diego 86
Shenyang 83
Jinan 79
Saint Petersburg 73
São Paulo 71
Da Nang 69
Guangzhou 68
Mülheim 68
Frankfurt am Main 64
Nanchang 61
Bern 59
Redondo Beach 59
Changsha 58
Shanghai 54
Sofia 53
Phoenix 49
Rome 49
Bengaluru 48
Bangkok 46
Dearborn 46
Haiphong 45
Florence 44
Jakarta 44
Chicago 43
Des Moines 43
Hebei 42
London 42
Mahé 42
Tianjin 40
Verona 38
Brussels 36
Orem 36
Zhengzhou 34
Olalla 33
San Francisco 31
Munich 29
Ningbo 27
Atlanta 26
Bremen 25
Jiaxing 25
Amman 24
Mexico City 24
Redwood City 24
Abeokuta 23
Johannesburg 23
Nuremberg 23
Toronto 23
Falkenstein 22
Hangzhou 22
Redmond 22
Wuhan 22
Kuban 21
Manila 21
Medford 21
Baghdad 20
Brooklyn 20
Taizhou 20
Amsterdam 19
Totale 19.823
Salva come PNG Salva come JPEG
Nome #
metodo e kit per la diagnosi prenatale di cardiopatie congenite 503
Highly active antiretroviral therapy in a resourse-limited setting: impact on the pregnancy outcome of HIV-infected women. 414
Changes in Artery Diameters and Fetal Growth in Cases of Isolated Single Umbilical Artery 298
Accuracy of fetal gender determination in the first trimester using three-dimensional ultrasound. 289
Circulating mRNA for the PLAC1 Gene as a Second Trimester Marker (14-18 Weeks' Gestation) in the Screening for Late Preeclampsia 287
First trimester risk of preeclampsia and rate of spontaneous birth in patients without preeclampsia 282
Fetal cardiac defects and third-trimester maternal serum placental growth factor 280
Brainstem-vermis and brainstem-tentorium angles allow accurate categorization of fetal upward rotation of cerebellar vermis 277
P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study. 264
Intrahepatic Cholestasis of Pregnancy: mRNAs for LIPF and ELOVL4 Genes Are Not Detectable in Circulating Maternal Plasma. 250
Gene Expression Profile Analysis in Human T Lymphocytes from Patients with Down Syndrome. 245
PLAC1 mRNA in maternal blood correlates with Doppler waveform in uterine arteries in normal pregnancies at the second and third trimester. 243
Prenatal diagnosis of a complete mole coexisting with a dichorionic twin pregnancy: case report. 236
Circulating corticotropin-releasing hormone mRNA in maternal plasma: relationship with gestational age and severity of preeclampsia. 234
Heat shock response by EBV-immortalized B-lymphocytes from centenarians and control subjects: A model to study the relevance of stress response in longevity 232
Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy. 227
Performance of peripheral (serum and molecular) blood markers for diagnosis of endometriosis. 227
IN GRAVIDANZE A TERMINE SOTTOPOSTE A INDUZIONE I LIVELLI DELL’mRNA DEL PLAC1 NEL SANGUE MATERNO SONO CORRELATI CON L’INTERVALLO DI TEMPO CHE INTERCORRE TRA LA PRIMA SOMMINISTRAZIONE DI GEL A BASE DI DINOPROSTONE E IL PARTO 226
Amniocentesis and chorionic villus sampling in twin gestations: which is the best sampling technique 225
Maternal prepregnancy weight as an independent risk factor for congenital heart defect: systematic review and meta-analysis stratified by subtype and severity of defect 225
Dynamic changes of fetal head descent at term before the onset of labor correlate with labor outcome and can be improved by ultrasound visual feedback 223
Matrix metalloproteinase-3 mRNA: a promising peripheral blood marker for diagnosis of endometriosis. 222
High Doses of Ursodeoxycholic Acid Up-Regulate the Expression of Placental Breast Cancer Resistance Protein in Patients Affected by Intrahepatic Cholestasis of Pregnancy 218
Prognostic value of pelvic lymphadenectomy in surgical treatment of apparent stage I endometrial cancer. 213
Parvovirus B19 in pregnancy: possible consequences of vertical transmission. 212
Cell-free fetal DNA (SRY locus) concentration in maternal plasma is directly correlated to the time elapsed from the onset of preeclampsia to the collection of blood. 204
Total activin A in maternal blood as a marker of preterm delivery in low-risk asymptomatic patients 203
PLAC4 and beta-HCG mRNA levels are not altered in the maternal circulation of pregnancy with trisomy 21 201
The impact of assisted reproductive technology and chorionicity in twin pregnancies complicated by obstetric cholestasis 198
Cell-Free DNA (cfDNA) Fetal Fraction in Early- and Late-Onset Fetal Growth Restriction 196
Changes in Vaginal Physiology of Menopausal Women with Type 2 Diabetes 195
Time profile of appearance and disappearance of circulating placenta-derived mRNA in maternal plasma. 188
Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop preeclampsia later in pregnancy: implications for screening. 187
Vaginal cuff dehiscence after hysterectomy: a multicenter retrospective study. 184
Multivariable evaluation of term birth weight: a comparison between ultrasound biometry and symphysis-fundal height 184
Elevated maternal placental protein 13 serum levels at term of pregnancy in postpartum major hemorrhage (>1000 mLs). A prospective cohort study 184
Congenital heart defects: is it time to explore maternal blood for a non-invasive genetic screening test? 183
Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls. 183
Umbilical cord insertion into the lower segment of the uterus at 11 to 13 weeks' gestation is associated with maternal serum PAPP-A. 182
Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop pre-eclampsia later in pregnancy: implications for screening. 181
Velamentous cord insertion and atypical variable decelerations with no accelerations. 180
Ultrasound prediction of symptomatic congenital cytomegalovirus infection 180
Identification of circulating placental mRNA in maternal blood of pregnancies affected with fetal congenital heart diseases at the second trimester of pregnancy: implications for early molecular screening. 178
IMPATTO DELLE INDAGINI DIAGNOSTICHE DI APPROFONDIMENTO E DEL COUNSELLING SULLA PERCENTUALE DI INTERRUZIONI VOLONTARIE DI GRAVIDANZA NELLE DONNE CON RISCONTRO DI IMMUNOGLOBULINE M ANTI-CITOMEGALOVIRUS AL TEST DI SCREENING 177
Cord insertion into the lower third of the uterus in the first trimester is associated with placental and umbilical cord abnormalities 177
Evidence of genetic underexpression in chorionic villi samples of euploid fetuses with increased nuchal translucency at 10-11 weeks' gestation 177
Fragmentation of cell-free fetal DNA in plasma and urine of pregnant women. 176
Circulating mRNA for epidermal growth factor-like domain 7 (EGFL7) in maternal blood and early intrauterine growth restriction. A preliminary analysis 176
Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients. 175
Cell-Free Fetal DNA for the Prediction of Pre-Eclampsia at the First and Second Trimesters: A Systematic Review and Meta-Analysis 175
Automated Measurement of the Angle of Progression in Labor: A Feasibility and Reliability Study 175
PLAC1 mRNA levels in maternal blood at induction of labor correlate negatively with induction-delivery interval. 175
Non-syndromic orofacial clefts in Southern Italy: pattern analysis according to gender, history of maternal smoking, folic acid intake and familial diabetes. J Craniomaxillofac Surg. 172
Ultrasound screening for congenital pyelectasis in term pregnancies 172
Analysis of the ultrasonographic findings predictive of vasa previa. 171
Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia. 171
The Tei index for evaluation of fetal myocardial performance in sick fetuses 169
A First-Trimester Biomarker Panel for Predicting the Development of Gestational Diabetes 169
Delivery and immigration: the experience of an Italian hospital. 169
Antioxidant supplementation in pregnant women with low antioxidant status. 168
Cell-free mRNA concentrations of CRH, PLAC1, and selectin-P are increased in the plasma of pregnant women with preeclampsia. 167
Lower maternal PLAC1 mRNA in pregnancies complicated with vaginal bleeding (threatened abortion <20 weeks) and a surviving fetus. 167
Circulating mRNA in Maternal Plasma at the Second Trimester of Pregnancy: A Possible Screening Tool for Cardiac Conotruncal and Left Ventricular Outflow Tract Abnormalities 167
Biophysical markers for abnormal placentation: first and/or second trimester 167
Delaire's cheilorhinoplasty: Unilateral cleft aesthetic outcome scored according to the EUROCLEFT guidelines 166
Akt, protein kinase C, and mitogen-activated protein kinase phosphorylation status in head and neck squamous cell carcinoma. 166
Measurement of mRNA of trophoblast-specific genes in cellular and plasma components of maternal blood. 165
TGF Alpha Has Low Protein Expression in Nonsyndromic Clefts. 163
An innovative test for non-invasive Kell genotyping on circulating fetal DNA by means of the allelic discrimination of K1 and K2 antigens 162
Cellular mRNA expressions of anti-oxidant factors in the blood of preeclamptic women. 159
Predizione ecografica dell’infezione congenita sintomatica da cytomegalovirus 158
Rapid clearance of mRNA for PLAC1 gene in maternal blood after delivery. 157
LA CRIOCONSERVAZIONE DEI GAMETI: IMPLICAZIONI ALLA LUCE DELLA LEGGE 40/2004 157
Non-Invasive Detection of a De Novo Frameshift Variant of STAG2 in a Female Fetus: Escape Genes Influence the Manifestation of X-Linked Diseases in Females 156
Performance of Circulating Placental Growth Factor as A Screening Marker for Diagnosis of Ovarian Endometriosis: A Pilot Study 155
Prospective evaluation of the risk of pre-eclampsia using logistic regression analysis. 155
Diagnosis of station and rotation of the fetal head in the second stage of labor with intrapartum translabial ultrasound. 153
Bcl-2 as prognostic factor in head and neck squamous cell carcinoma. 153
PP13 mRNA expression in the cellular component of maternal blood as a marker for preeclampsia. 152
Time remaining in labor and probability of vaginal delivery as a function of the angle of progression in a low risk population with a normal first stage of labor. In-house observational study and comparison with the data in the literature 152
Prenatal screening for developmental displacement of the hip: The buddha (pre-birth ultrasound for developmental displacement of the hip assessment) study 152
Impatto della HAART(Higly Active Antiretroviral Therapy) sull’outcome delle gravidanze di donne HIV positive in contesti a risorse limitate 151
Three-dimensional ultrasound is an accurate and reproducible technique for fetal crown-rump length measureme 151
Reference ranges of uterine arteries pulsatility index from first to third trimester based on serial Doppler measurements: longitudinal cohort study 150
Effect of c-Met expression on survival in head and neck squamous cell carcinoma. 150
Higher circulating mRNA levels of placental specific genes in a patient with placenta accreta. 150
Normal morphometry of fetal posterior fossa at midtrimester: brainstem-tentorium angle and brainstem-vermis angle. 150
Prospective longitudinal cohort study of uterine arteries Doppler in singleton pregnancies obtained by IVF/ICSI with oocyte donation or natural conception 150
Abnormal circulating maternal mirna expression is associated with a low (<4%) cell-free dna fetal fraction 150
Maternal plasma mRNA species in fetal heart defects: a potential for molecular screening 149
Levels of Circulating mRNA for the Tenascin-X (TNXB) Gene in Maternal Plasma at the Second Trimester in Pregnancies with Isolated Congenital Ventricular Septal Defects 149
A practical approach for the management of obstetric and infertile women during the phase two of the novel coronavirus disease 2019 (COVID ‐19) pandemic 149
Performance of a panel of maternal serum markers in predicting preeclampsia at 11-15 weeks' gestation. 148
Infezione da HIV e gravidanza: profilassi versus terapia antiretrovirale altamente efficace 147
P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation 147
Clinical outcome of 285 Medpor grafts used for craniofacial reconstruction. 146
Impact of HAART (Highly Active Antiretroviral Therapy) on the outcome of pregnancy in a resource-limited setting 146
Prospective evaluation of ultrasound and biochemical‐based multivariable models for the prediction of late pre‐eclampsia 145
Caesarean scar pregnancy complicated by placenta percreta followed by suppurative appendicitis after conservative management with methotrexate 145
The 36-week preeclampsia risk by the Fetal Medicine Foundation algorithm is associated with fetal compromise following induction of labor 144
Totale 19.053
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.442
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 364
Totale 88.806
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.155 201 91 240 359 317 151 86 229 114 185 599 583
2022/20233.300 395 479 193 399 210 236 91 175 490 116 342 174
2023/2024892 94 157 81 94 78 130 45 64 24 49 29 47
2024/20253.615 155 553 318 264 512 249 219 98 73 197 139 838
2025/202610.542 923 1.221 1.014 786 1.190 674 1.127 301 1.588 725 515 478
2026/2027412 412 0 0 0 0 0 0 0 0 0 0 0
Totale 31.668